JP2023526225A5 - - Google Patents
Info
- Publication number
- JP2023526225A5 JP2023526225A5 JP2022568714A JP2022568714A JP2023526225A5 JP 2023526225 A5 JP2023526225 A5 JP 2023526225A5 JP 2022568714 A JP2022568714 A JP 2022568714A JP 2022568714 A JP2022568714 A JP 2022568714A JP 2023526225 A5 JP2023526225 A5 JP 2023526225A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- wild
- acid position
- position corresponding
- type
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063023083P | 2020-05-11 | 2020-05-11 | |
| US63/023,083 | 2020-05-11 | ||
| US202063122417P | 2020-12-07 | 2020-12-07 | |
| US63/122,417 | 2020-12-07 | ||
| PCT/US2021/031826 WO2021231464A1 (en) | 2020-05-11 | 2021-05-11 | Compositions for increasing half-life of a therapeutic agent in canines and methods of use |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023526225A JP2023526225A (ja) | 2023-06-21 |
| JP2023526225A5 true JP2023526225A5 (https=) | 2024-05-21 |
| JP7832123B2 JP7832123B2 (ja) | 2026-03-17 |
Family
ID=76375622
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022568714A Active JP7832123B2 (ja) | 2020-05-11 | 2021-05-11 | 治療薬のイヌにおける半減期を増加させるための組成物及びその使用方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US11434276B2 (https=) |
| EP (1) | EP4149969A1 (https=) |
| JP (1) | JP7832123B2 (https=) |
| KR (1) | KR20230034954A (https=) |
| CN (2) | CN120590527A (https=) |
| AU (1) | AU2021270564A1 (https=) |
| BR (1) | BR112022022922A2 (https=) |
| CA (1) | CA3178123A1 (https=) |
| MX (1) | MX2022014150A (https=) |
| WO (1) | WO2021231464A1 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12297272B2 (en) | 2017-08-15 | 2025-05-13 | Eianco US inc. | IgG Fc variants for veterinary use |
| CN113544153B (zh) | 2019-01-03 | 2024-12-10 | 因外泰克斯公司 | 用于增加治疗剂在犬中的半衰期的组合物及使用方法 |
| KR20230038522A (ko) | 2020-07-10 | 2023-03-20 | 인베티엑스 인코포레이티드 | 고양이에서 치료제의 반감기를 증가시키기 위한 조성물 및 사용 방법 |
| EP4255933A4 (en) * | 2020-12-07 | 2025-07-23 | Invetx Inc | COMPOSITIONS FOR INCREASING THE HALF-LIFE OF A THERAPEUTIC AGENT IN LIVESTOCK ANIMALS AND METHODS OF USE |
| AU2022329459A1 (en) | 2021-08-20 | 2024-02-29 | Intervet International B.V. | Antibodies and igg fusion proteins with an extended half-life |
| US20240209096A1 (en) * | 2022-12-27 | 2024-06-27 | Invetx, Inc. | Polypeptides with altered binding to neonatal fc receptor (fcrn) and methods of use |
| AU2024210302A1 (en) | 2023-01-20 | 2025-09-04 | Invetx, Inc. | Bispecific binding agents for use in companion animals |
| EP4662227A1 (en) * | 2023-02-08 | 2025-12-17 | Levicept Limited | Fusion protein |
| MX2025013878A (es) * | 2023-05-22 | 2026-02-03 | Invetx Inc | Composiciones farmaceuticas para anticuerpos y su elaboracion y uso |
| GB202311984D0 (en) * | 2023-08-04 | 2023-09-20 | Petmedix Ltd | Optimised fc molecules |
Family Cites Families (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5179017A (en) | 1980-02-25 | 1993-01-12 | The Trustees Of Columbia University In The City Of New York | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
| US4399216A (en) | 1980-02-25 | 1983-08-16 | The Trustees Of Columbia University | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
| US4634665A (en) | 1980-02-25 | 1987-01-06 | The Trustees Of Columbia University In The City Of New York | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
| US4447233A (en) | 1981-04-10 | 1984-05-08 | Parker-Hannifin Corporation | Medication infusion pump |
| US4439196A (en) | 1982-03-18 | 1984-03-27 | Merck & Co., Inc. | Osmotic drug delivery system |
| US4447224A (en) | 1982-09-20 | 1984-05-08 | Infusaid Corporation | Variable flow implantable infusion apparatus |
| US4487603A (en) | 1982-11-26 | 1984-12-11 | Cordis Corporation | Implantable microinfusion pump system |
| US5683888A (en) | 1989-07-22 | 1997-11-04 | University Of Wales College Of Medicine | Modified bioluminescent proteins and their use |
| US5292658A (en) | 1989-12-29 | 1994-03-08 | University Of Georgia Research Foundation, Inc. Boyd Graduate Studies Research Center | Cloning and expressions of Renilla luciferase |
| ES2142801T3 (es) | 1991-03-11 | 2000-05-01 | Univ Georgia Res Found | Clonacion y expresion de luciferasa de renilla. |
| EP0759170B1 (en) | 1993-09-10 | 2008-07-09 | The Trustees Of Columbia University In The City Of New York | Uses of green fluorescent protein |
| WO1995021191A1 (en) | 1994-02-04 | 1995-08-10 | William Ward | Bioluminescent indicator based upon the expression of a gene for a modified green-fluorescent protein |
| US5777079A (en) | 1994-11-10 | 1998-07-07 | The Regents Of The University Of California | Modified green fluorescent proteins |
| US5874304A (en) | 1996-01-18 | 1999-02-23 | University Of Florida Research Foundation, Inc. | Humanized green fluorescent protein genes and methods |
| US5804387A (en) | 1996-02-01 | 1998-09-08 | The Board Of Trustees Of The Leland Stanford Junior University | FACS-optimized mutants of the green fluorescent protein (GFP) |
| US5876995A (en) | 1996-02-06 | 1999-03-02 | Bryan; Bruce | Bioluminescent novelty items |
| US5925558A (en) | 1996-07-16 | 1999-07-20 | The Regents Of The University Of California | Assays for protein kinases using fluorescent protein substrates |
| US5976796A (en) | 1996-10-04 | 1999-11-02 | Loma Linda University | Construction and expression of renilla luciferase and green fluorescent protein fusion genes |
| IL129767A0 (en) | 1996-12-12 | 2000-02-29 | Prolume Ltd | Apparatus and method for detecting and identifying infectious agents |
| JP2002507410A (ja) | 1998-03-27 | 2002-03-12 | プロルーム・リミテッド | ルシフェラーゼ、蛍光タンパク質、ルシフェラーゼおよび蛍光タンパク質をコードする核酸および、診断、高処理スクリーニングおよび新規アイテムにおけるその使用 |
| US7658921B2 (en) | 2000-12-12 | 2010-02-09 | Medimmune, Llc | Molecules with extended half-lives, compositions and uses thereof |
| WO2005047327A2 (en) | 2003-11-12 | 2005-05-26 | Biogen Idec Ma Inc. | NEONATAL Fc RECEPTOR (FcRn)-BINDING POLYPEPTIDE VARIANTS, DIMERIC Fc BINDING PROTEINS AND METHODS RELATED THERETO |
| AU2005285347A1 (en) | 2004-08-19 | 2006-03-23 | Genentech, Inc. | Polypeptide variants with altered effector function |
| US8367805B2 (en) | 2004-11-12 | 2013-02-05 | Xencor, Inc. | Fc variants with altered binding to FcRn |
| EP2411050A4 (en) * | 2009-03-25 | 2013-07-17 | Vet Therapeutics Inc | ANTIBODY REGIONS WITH A CONSTANT DOMAIN AND THEIR USE |
| WO2010117448A2 (en) * | 2009-04-05 | 2010-10-14 | Provenance Biopharmaceuticals Corp. | Chimeric immunocytokines and methods of use thereof |
| US8790651B2 (en) | 2011-07-21 | 2014-07-29 | Zoetis Llc | Interleukin-31 monoclonal antibody |
| US20130129727A1 (en) | 2011-11-17 | 2013-05-23 | Nanjingjinsirui Science & Technology Biology Corporation | Methods and systems for increasing protein stability |
| EP3448427A1 (en) | 2016-04-29 | 2019-03-06 | CureVac AG | Rna encoding an antibody |
| EP3481413A4 (en) | 2016-07-08 | 2020-01-08 | Askgene Pharma, Inc. | FUSION PROTEIN WITH LEPTIN AND METHOD FOR THE PRODUCTION AND USE THEREOF |
| US20200181258A1 (en) | 2016-10-17 | 2020-06-11 | Vetoquinol Sa | Modified antibody constant region |
| US12297272B2 (en) | 2017-08-15 | 2025-05-13 | Eianco US inc. | IgG Fc variants for veterinary use |
| IL276286B2 (en) * | 2018-01-26 | 2025-07-01 | Genzyme Corp | FC variants with improved binding to FCRN and extended half-life |
| BR112020017701A2 (pt) | 2018-03-12 | 2020-12-29 | Zoetis Services Llc | Anticorpos anti-ngf e métodos dos mesmos |
| JP2022500037A (ja) | 2018-09-14 | 2022-01-04 | キンドレッド バイオサイエンシズ インコーポレイテッド | 獣医学的使用のための抗ｉｌ４受容体抗体 |
| US20210388053A1 (en) | 2018-10-18 | 2021-12-16 | Kindred Biosciences, Inc. | Fc Variants with Altered Binding to Neonatal Fc Receptor (FCRN) for Veterinary Use |
| JP7536294B2 (ja) | 2018-12-05 | 2024-08-20 | 株式会社バイカ・セラピュティクス | 抗体のＦｃ領域改変体 |
| CN120904316A (zh) | 2018-12-27 | 2025-11-07 | 伊兰科美国公司 | 兽用IgG Fc变体 |
| CN113544153B (zh) | 2019-01-03 | 2024-12-10 | 因外泰克斯公司 | 用于增加治疗剂在犬中的半衰期的组合物及使用方法 |
| WO2021165417A1 (en) | 2020-02-19 | 2021-08-26 | Adivo Gmbh | Modified fc regions |
| CN115996949A (zh) | 2020-04-17 | 2023-04-21 | 硕腾服务有限责任公司 | 犬抗体变异体 |
| MX2022012793A (es) | 2020-04-17 | 2022-11-07 | Zoetis Services Llc | Variantes de anticuerpos felinos. |
| KR20230038522A (ko) | 2020-07-10 | 2023-03-20 | 인베티엑스 인코포레이티드 | 고양이에서 치료제의 반감기를 증가시키기 위한 조성물 및 사용 방법 |
-
2021
- 2021-05-11 CN CN202510697382.6A patent/CN120590527A/zh active Pending
- 2021-05-11 KR KR1020227043402A patent/KR20230034954A/ko active Pending
- 2021-05-11 JP JP2022568714A patent/JP7832123B2/ja active Active
- 2021-05-11 US US17/317,782 patent/US11434276B2/en active Active
- 2021-05-11 AU AU2021270564A patent/AU2021270564A1/en active Pending
- 2021-05-11 CN CN202180048682.1A patent/CN115867572B/zh active Active
- 2021-05-11 BR BR112022022922A patent/BR112022022922A2/pt unknown
- 2021-05-11 MX MX2022014150A patent/MX2022014150A/es unknown
- 2021-05-11 EP EP21731617.3A patent/EP4149969A1/en active Pending
- 2021-05-11 WO PCT/US2021/031826 patent/WO2021231464A1/en not_active Ceased
- 2021-05-11 CA CA3178123A patent/CA3178123A1/en active Pending
-
2022
- 2022-07-28 US US17/875,934 patent/US20230127241A1/en active Pending
-
2024
- 2024-01-30 US US18/426,898 patent/US20240327497A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023526225A5 (https=) | ||
| WO2020142625A4 (en) | Compositions for increasing half-life of a therapeutic agent in canines and methods of use | |
| JP2023534636A5 (https=) | ||
| JP2866706B2 (ja) | 腫瘍壊死因子結合蛋白 | |
| US11987609B2 (en) | Proteinaceous heterodimer and use thereof | |
| US11667704B2 (en) | Anti-IL-17 antibody/TNFR ECD fusion protein and use thereof | |
| CN118063619A (zh) | 工程化的异源二聚体蛋白质 | |
| RU2715606C2 (ru) | СЛИТАЯ С Fc α-ЦЕПЬ ВЫСОКОАФФИННОГО РЕЦЕПТОРА IgE | |
| JPH04504363A (ja) | 組換え抗体―毒素融合タンパク質 | |
| JPH06315394A (ja) | Ｔｎｆリガンド | |
| CN112062854A (zh) | 用于治疗肠癌的双特异性融合蛋白抗体及其应用 | |
| JP2023552456A5 (https=) | ||
| US20080292628A1 (en) | Chimeric Protein | |
| JP3907661B2 (ja) | インターフェロン−α／β結合タンパク質、その製造法およびそれを含有する医薬組成物 | |
| CN117264054B (zh) | 靶向il-6的纳米抗体、组合物、方法及用途 | |
| US20220227827A1 (en) | Proteinaceous heterodimer and use thereof | |
| AU2020270242B2 (en) | Anti-TNF-α humanized monoclonal antibody TCX060 having low immunogenicity and low ADCC/CDC function, and use thereof | |
| ES2236696T3 (es) | Proteina de union de interferon-alfa/beta, su preparacion y su uso. | |
| CN119101167A (zh) | 一种用于新型冠状病毒感染治疗的双功能融合蛋白及其应用 | |
| KR20250117442A (ko) | TNF-α 및 IL-17A를 표적하는 이중특이적 융합 단백질 및 이의 용도 | |
| TWI825214B (zh) | 抗TNFα/抗IL-17A天然抗體結構樣異源二聚體形式雙特異抗體及其製備 | |
| JP2024534257A (ja) | 二重特異性組換えタンパク質及びその使用 | |
| RU2021122918A (ru) | Композиции для увеличения периода полужизни терапевтического средства у собак и способы применения | |
| CN111100211B (zh) | 一种Fc融合蛋白及其应用 |